Investigating the functional roles of GP73 in immune cells within inflammatory microenvironments could provide a theoretical basis for developing GP73 inhibitors, enhancing its potential as a drug target against infectious diseases, immune diseases and tumor via perfecting the microenvironment. This evidence concerns the gene GOLM1 and neoplasm.